Paul Tudor Jones’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.63M Buy
97,500
+72,700
+293% +$5.86M 0.01% 999
2026
Q1
$2.15M Buy
24,800
+5,300
+27% +$508K ﹤0.01% 1795
2025
Q4
$1.87M Sell
19,500
-28,000
-59% -$2.72M ﹤0.01% 1851
2025
Q3
$4.52M Sell
47,500
-11,200
-19% -$1.03M 0.01% 1254
2025
Q2
$5.12M Buy
58,700
+54,200
+1,204% +$4.6M 0.01% 1075
2025
Q1
$404K Sell
4,500
-36,600
-89% -$3.28M ﹤0.01% 2406
2024
Q4
$3.28M Sell
41,100
-14,500
-26% -$1.26M 0.01% 930
2024
Q3
$5.01M Buy
55,600
+15,100
+37% +$1.27M 0.02% 706
2024
Q2
$3.19M Sell
40,500
-12,400
-23% -$1.02M 0.02% 840
2024
Q1
$4.61M Buy
52,900
+21,400
+68% +$1.83M 0.03% 640
2023
Q4
$2.59M Buy
31,500
+7,000
+29% +$533K 0.02% 967
2023
Q3
$1.92M Buy
24,500
+17,700
+260% +$1.48M 0.02% 946
2023
Q2
$599K Buy
+6,800
New +$585K 0.01% 1612
2023
Q1
Sell
-24,700
Closed -$1.92M 2744
2022
Q4
$1.92M Buy
24,700
+20,000
+426% +$1.62M 0.04% 658
2022
Q3
$379K Buy
+4,700
New +$422K 0.01% 1599

Other funds holding MDT

Paul Tudor Jones's MDT Position: Q2 2026 in Review

Paul Tudor Jones increased its Medtronic (MDT) stake by 1,330% in Q2 2026, buying an estimated $4.93M and bringing the position to 65,665 shares worth $5.14M. The position accounts for 0.01% of the portfolio, ranked #1260.

Paul Tudor Jones first reported a position in MDT in Q2 2013 and has held it in 42 quarters since. The position peaked at $29M in Q1 2023. 2,126 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Paul Tudor Jones held 65,665 shares of Medtronic worth $5.14M as of Q2 2026.
  • Paul Tudor Jones bought 61,074 Medtronic shares in Q2 2026, an estimated $4.93M.
  • Medtronic made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #1260 holding.
  • Paul Tudor Jones first reported a position in Medtronic in Q2 2013 and has held it in 42 quarters since.
  • Paul Tudor Jones's Medtronic position peaked at $29M in Q1 2023.
  • 2,126 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.